Age-Related Eye Disease Study 2

Active Clinical Trials // Feb 12 2018

Age-Related Eye Disease Study 2 (AREDS2) 10-Year Follow-On Study

Sponsor: National Eye Institute (NEI)

Principal Investigator: Barbara Blodi, MD

Study Coordinator: Angie Adler

Study Objective:

Provide additional data regarding the incidence of advanced AMD, cataract surgery and lung cancer as well as obtain additional imaging data in the approximately 1,200 AREDS2 study participants enrolled in selected AREDS2 clinical sites.

Study Design:

This is an extension of the multicenter, randomized trial of lutein, zeaxanthin and omega-3 polyunsaturated fatty acids in age related macular degeneration AREDS2 trial. Data for this extension will be collected by staff at selected AREDS2 clinical sites via an in-clinic visit.

Inclusion Criteria:

To participate in this study, the potential participant must meet all of the following criteria:

a. Previously enrolled in the AREDS2 and AREDS2 Follow-on protocols at one of the selected sites for the 10-year follow-up visit.

Duration: One-time in-clinic visit (approximately 5 years post-AREDS2 final study visit)

 

For more information, contact Angie Adler 608-265-7557